ABL Diagnostics (XPAR:ABLD) EV-to-Revenue : 4.34 (As of Jun. 09, 2024)

View and export this data going back to 1989. Start your Free Trial

What is ABL Diagnostics EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, ABL Diagnostics's enterprise value is €50.46 Mil. ABL Diagnostics's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €11.63 Mil. Therefore, ABL Diagnostics's EV-to-Revenue for today is 4.34.

The historical rank and industry rank for ABL Diagnostics's EV-to-Revenue or its related term are showing as below:

XPAR:ABLD' s EV-to-Revenue Range Over the Past 10 Years
Min: -13.67 Med: 9.63 Max: 315.79
Current: 4.34

During the past 13 years, the highest EV-to-Revenue of ABL Diagnostics was 315.79. The lowest was -13.67. And the median was 9.63.

XPAR:ABLD's EV-to-Revenue is ranked worse than
74.44% of 665 companies
in the Healthcare Providers & Services industry
Industry Median: 1.85 vs XPAR:ABLD: 4.34

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-09), ABL Diagnostics's stock price is €3.04. ABL Diagnostics's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €0.72. Therefore, ABL Diagnostics's PS Ratio for today is 4.22.

ABL Diagnostics EV-to-Revenue Historical Data

The historical data trend for ABL Diagnostics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Diagnostics EV-to-Revenue Chart

ABL Diagnostics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EV-to-Revenue

Get a 7-Day Free Trial

2.41

26.81

ABL Diagnostics Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EV-to-Revenue	Get a 7-Day Free Trial															-	-	-	26.81	-

Competitive Comparison of ABL Diagnostics's EV-to-Revenue

For the Health Information Services subindustry, ABL Diagnostics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ABL Diagnostics's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ABL Diagnostics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where ABL Diagnostics's EV-to-Revenue falls into.

ABL Diagnostics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

ABL Diagnostics's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	50.456	/	11.625
	=	4.34

ABL Diagnostics's current Enterprise Value is €50.46 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ABL Diagnostics's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €11.63 Mil.

ABL Diagnostics (XPAR:ABLD) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

ABL Diagnostics's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	3.04	/	0.721
	=	4.22

ABL Diagnostics's share price for today is €3.04.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2023 was €0.72.

ABL Diagnostics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of ABL Diagnostics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

ABL Diagnostics (XPAR:ABLD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ABL Diagnostics (XPAR:ABLD) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

72c, rue de, WOIPPY, Thionville, FRA, 57140

Website

https://www.abldiagnostics.com

ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.

ABL Diagnostics (XPAR:ABLD) Headlines

No Headlines